Jackson Creek Investment Advisors LLC Medpace Holdings, Inc. Transaction History

Jackson Creek Investment Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$372.0 - $424.34 $33,480 - $38,190	-90 Reduced 2.98%	2,930 $1.21 Million
Q1 2024 May 09, 2024	SELL	$284.87 - $413.31 $471,174 - $683,614	-1,654 Reduced 35.39%	3,020 $1.22 Million
Q4 2023 Feb 05, 2024	SELL	$227.52 - $312.68 $20,931 - $28,766	-92 Reduced 1.93%	4,674 $1.43 Million
Q3 2023 Nov 03, 2023	SELL	$233.98 - $281.67 $4,913 - $5,915	-21 Reduced 0.44%	4,766 $1.15 Million
Q2 2023 Aug 02, 2023	BUY	$187.26 - $240.17 $46,815 - $60,042	250 Added 5.51%	4,787 $1.15 Million
Q1 2023 May 02, 2023	SELL	$174.31 - $239.52 $1,220 - $1,676	-7 Reduced 0.15%	4,537 $853,000
Q4 2022 Feb 03, 2023	SELL	$153.06 - $226.57 $148,927 - $220,452	-973 Reduced 17.64%	4,544 $965,000
Q3 2022 Nov 09, 2022	BUY	$145.13 - $182.49 $800,682 - $1.01 Million	5,517 New	5,517 $867,000
Q4 2020 Feb 03, 2021	SELL	$109.38 - $149.19 $730,767 - $996,738	-6,681 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$92.95 - $130.61 $620,998 - $872,605	6,681 New	6,681 $747,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.